Evogene (EVGN) Short Interest Ratio & Short Volume → The AI stock to buy right now (From StockEarnings) (Ad) Free EVGN Stock Alerts $0.71 -0.01 (-1.40%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Evogene Short Interest DataCurrent Short Volume69,700 sharesPrevious Short Volume86,500 sharesChange Vs. Previous Month-19.42%Dollar Volume Sold Short$47,835.11Short Interest Ratio / Days to Cover0.4Last Record DateApril 15, 2024Outstanding Shares41,216,000 sharesPercentage of Shares Shorted0.17%Today's Trading Volume45,927 sharesAverage Trading Volume67,427 sharesToday's Volume Vs. Average68% Short Selling Evogene ? Sign up to receive the latest short interest report for Evogene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEVGN Short Interest Over TimeEVGN Days to Cover Over TimeEVGN Percentage of Float Shorted Over Time Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Evogene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202469,700 shares $47,835.11 -19.4%N/A0.4 $0.69 3/31/202486,500 shares $64,875.00 +20.8%N/A0.5 $0.75 3/15/202471,600 shares $58,712.00 -47.5%N/A0.4 $0.82 2/29/2024136,300 shares $124,196.56 +25.7%N/A0.6 $0.91 2/15/2024108,400 shares $81,137.40 -11.0%N/A0.5 $0.75 1/31/2024121,800 shares $93,177.00 -3.0%N/A0.8 $0.77 Get the Latest News and Ratings for EVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024125,500 shares $117,719.00 -18.4%N/A0.8 $0.94 12/31/2023153,700 shares $129,108.00 -17.9%N/A1 $0.84 12/15/2023187,200 shares $131,189.76 -35.0%N/A1.3 $0.70 11/30/2023287,800 shares $187,127.56 +32.3%N/A2.3 $0.65 11/15/2023217,500 shares $143,898.00 +20.6%N/A2 $0.66 10/31/2023180,400 shares $86,429.64 -28.8%N/A1.3 $0.48 10/15/2023253,400 shares $118,616.54 -11.3%N/A1.6 $0.47 9/30/2023285,600 shares $167,504.40 +20.0%N/A1 $0.59 9/15/2023238,000 shares $159,698.00 -8.9%N/A0.7 $0.67 8/31/2023261,100 shares $194,075.63 -12.7%N/A0.7 $0.74 8/15/2023299,200 shares $238,163.20 -10.7%N/A0.8 $0.80 7/31/2023334,900 shares $354,994.00 -33.8%N/A1 $1.06 7/15/2023505,800 shares $708,120.00 -8.5%N/A1.7 $1.40 6/30/2023552,800 shares $591,496.00 +118.7%1.4%3.5 $1.07 6/15/2023252,800 shares $195,161.60 +13.0%0.6%2 $0.77 5/31/2023223,800 shares $134,324.76 -22.5%0.6%3.1 $0.60 5/15/2023288,700 shares $193,313.52 +13.4%0.7%3.9 $0.67 4/30/2023254,500 shares $149,111.55 -1.3%0.6%3.1 $0.59 4/15/2023257,900 shares $149,917.27 +2.6%0.7%2.8 $0.58 3/31/2023251,300 shares $158,319.00 +42.9%0.6%2.6 $0.63 3/15/2023175,900 shares $115,918.10 +11.2%0.4%1.6 $0.66 2/28/2023158,200 shares $120,232.00 -31.2%0.4%1.5 $0.76 2/15/2023230,000 shares $195,500.00 -7.9%0.6%2.1 $0.85 1/31/2023249,600 shares $199,655.04 +45.0%0.6%2.4 $0.80 1/15/2023172,200 shares $129,150.00 -0.9%0.4%1.9 $0.75 12/30/2022173,800 shares $121,660.00 -35.2%0.4%2 $0.70 12/15/2022268,100 shares $189,653.94 +42.6%0.7%2.9 $0.71 11/30/2022188,000 shares $117,970.00 -5.8%0.5%2.5 $0.63 11/15/2022199,600 shares $143,712.00 -19.4%0.5%2.5 $0.72 10/31/2022247,500 shares $180,675.00 +23.9%0.6%2.6 $0.73 10/15/2022199,700 shares $141,767.03 +3.2%0.5%1.9 $0.71 9/30/2022193,500 shares $160,605.00 -9.8%0.5%1.8 $0.83 9/15/2022214,400 shares $218,688.00 -1.1%0.6%1.9 $1.02 8/31/2022216,700 shares $225,368.00 +22.9%0.6%1.8 $1.04Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now EVGN Short Interest - Frequently Asked Questions What is Evogene's current short interest? Short interest is the volume of Evogene shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 69,700 shares of EVGN short. Learn More on Evogene's current short interest. Is Evogene's short interest increasing or decreasing? Evogene saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 69,700 shares, a decline of 19.4% from the previous total of 86,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Evogene's short interest compare to its competitors? Here is how the short interest of companies compare to Evogene: bioAffinity Technologies, Inc. (4.35%), Pluri Inc. (0.91%), Femasys Inc. (5.84%), Spruce Biosciences, Inc. (0.74%), NeuroOne Medical Technologies Co. (1.40%), Aprea Therapeutics, Inc. (2.01%), Singular Genomics Systems, Inc. (1.42%), DURECT Co. (3.19%), Achilles Therapeutics plc (0.10%), Nutriband Inc. (1.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Evogene stock? Short selling EVGN is an investing strategy that aims to generate trading profit from Evogene as its price is falling. EVGN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evogene? A short squeeze for Evogene occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVGN, which in turn drives the price of the stock up even further. How often is Evogene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVGN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: bioAffinity Technologies Short Interest Data Pluri Short Interest Data Femasys Short Interest Data Spruce Biosciences Short Interest Data NeuroOne Medical Technologies Short Interest Data Aprea Therapeutics Short Interest Data Singular Genomics Systems Short Interest Data DURECT Short Interest Data Achilles Therapeutics Short Interest Data Nutriband Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVGN) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBill Gates is all about this tiny $2 stockTimothy SykesNew Trump BombshellThe Freeport Society